stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Frei - Play StoreApp Store
InstallierenInstallieren
logo
Phio Pharmaceuticals CorpPHIO
$0.9032.61%0.023
Nachbörslich: 0.84-0.06 -6.98%

Phio Pharmaceuticals Corp (PHIO)

Date: 2026-11-03 16:00O: 0.8700H: 0.9197L: 0.8700C: 0.9030Vol: 33.70k
Schlusskurs vom Vortag:
$0.88
Offen:
$0.87
24-Stunden-Volumen:
33,013
Relatives Volumen:
0.71
Marktkapitalisierung:
$10.49M
Einnahmen:
$153.00K
Nettoeinkommen (Verlust:
-$10.93M
KGV:
-
EPS:
-$1.44
Netto-Cashflow:
-$10.72M
1W Leistung:
+1.32%
1M Leistung:
-8.33%
6M Leistung:
-20.79%
1Y Leistung:
-51.45%
1-Tages-Spanne:
$0.87$0.9197
1-Wochen-Bereich:
$0.85$0.9197
52-Wochen-Spanne:
$0.8127$4.19

Phio Pharmaceuticals Corp Aktie (PHIO) Unternehmensprofil

Firmenname
Phio Pharmaceuticals Corp
Telefon
(508) 767-3861
Adresse
411 SWEDELAND ROAD, KING OF PRUSSIA, MA, USA
Mitarbeiter
6
Nächster Verdiensttermin
2026-11-12
Neueste SEC-Einreichungen
SEC
PHIO-Diskussionen auf X
X

 

Marktkapitalisierung

 

Umsatz

 

Nettogewinn

 

Free Cashflow

 

ENV

 

Phio Pharmaceuticals Corp Aktie (PHIO) Hochstufungen & Herabstufungen

DatumAktionAnalytikerRatingänderung
2025-06-05ResumedH.C. WainwrightBuy
2020-08-05EingeleitetH.C. WainwrightBuy

Finanzdaten der Phio Pharmaceuticals Corp-Aktie (PHIO)

ZeitraumTrendFY 2025FY 2024FY 2023FY 2022FY 2021
Enddatum des Zeitraums2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue USD (M)--0.000.000.00
Research and development USD (M)4.623.646.337.018.89
Operating expenses USD (M)9.227.3910.8211.4613.51
Operating income USD (M)-9.22-7.39-10.82-11.46-13.51
Income before tax USD (M)---10.83-11.48-13.29
Income tax expense USD (M)0.000.000.000.000.00
Net income USD (M)-8.70-7.15-10.83-11.48-13.29
Basic EPS USD/shares-1.45-9.08-5.20-10.10-
Diluted EPS USD/shares--9.08-5.20-10.10-
Basic weighted shares shares (M)5.980.792.081.14-
Diluted weighted shares shares (M)-0.792.081.14-

Phio Pharmaceuticals Corp-Aktie (PHIO) Insiderhandel

  • Director
    Transaktion
    Buy
    Kosten
    $1.04
    #Aktien
    5,000
    Wert ($)
    5,200
    #Aktien Gesamt
    42,000
  • Director
    Transaktion
    Buy
    Kosten
    $1.03
    #Aktien
    5,000
    Wert ($)
    5,150
    #Aktien Gesamt
    37,000
  • Director
    Transaktion
    Buy
    Kosten
    $1.01
    #Aktien
    6,500
    Wert ($)
    6,583
    #Aktien Gesamt
    64,151
  • Chairman, Pres. & CEO
    Transaktion
    Buy
    Kosten
    $1.03
    #Aktien
    2,000
    Wert ($)
    2,058
    #Aktien Gesamt
    364,871
  • Director
    Transaktion
    Buy
    Kosten
    $1.03
    #Aktien
    12,000
    Wert ($)
    12,360
    #Aktien Gesamt
    57,651
  • Director
    Transaktion
    Buy
    Kosten
    $1.14
    #Aktien
    15,000
    Wert ($)
    17,100
    #Aktien Gesamt
    15,000
  • Chairman, Pres. & CEO
    Transaktion
    Buy
    Kosten
    $1.06
    #Aktien
    10,000
    Wert ($)
    10,600
    #Aktien Gesamt
    431,421
  • Chairman, Pres. & CEO
    Transaktion
    Buy
    Kosten
    $0.99
    #Aktien
    10,000
    Wert ($)
    9,900
    #Aktien Gesamt
    421,421
  • Chairman, Pres. & CEO
    Transaktion
    Buy
    Kosten
    $1.03
    #Aktien
    5,000
    Wert ($)
    5,150
    #Aktien Gesamt
    291,421
  • Chairman, Pres. & CEO
    Transaktion
    Buy
    Kosten
    $1.02
    #Aktien
    5,000
    Wert ($)
    5,100
    #Aktien Gesamt
    286,421
InsiderhandelBeziehungDatumTransaktionKosten#AktienWert ($)#Aktien Gesamt
Plott Ronald ToddDirectorSep 29 '26Buy$1.045,0005,20042,000
Plott Ronald ToddDirectorSep 28 '26Buy$1.035,0005,15037,000
BRADFORD PATRICIA ADirectorSep 24 '26Buy$1.016,5006,58364,151
Bitterman Robert JChairman, Pres. & CEOSep 22 '26Buy$1.032,0002,058364,871
BRADFORD PATRICIA ADirectorSep 15 '26Buy$1.0312,00012,36057,651
Plott Ronald ToddDirectorAug 19 '26Buy$1.1415,00017,10015,000
Bitterman Robert JChairman, Pres. & CEOAug 18 '26Buy$1.0610,00010,600431,421
Bitterman Robert JChairman, Pres. & CEOJun 26 '26Buy$0.9910,0009,900421,421
Bitterman Robert JChairman, Pres. & CEODec 31 '25Buy$1.035,0005,150291,421
Bitterman Robert JChairman, Pres. & CEODec 23 '25Buy$1.025,0005,100286,421

Phio Pharmaceuticals Corp Aktie (PHIO) Neueste Nachrichten

Oct 06, 2026
Oct 06, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Sep 30, 2026
Sep 30, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 25, 2026
Sep 25, 2026
Sep 25, 2026
Sep 25, 2026
Sep 23, 2026
Sep 23, 2026
Sep 23, 2026
Sep 23, 2026
Sep 18, 2026
Sep 18, 2026
Sep 17, 2026
Sep 17, 2026
Sep 16, 2026
Sep 16, 2026
Sep 15, 2026
Sep 15, 2026
Sep 15, 2026
Sep 15, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 11, 2026
Sep 11, 2026
Sep 11, 2026
Sep 11, 2026
Aug 30, 2026
Aug 30, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 14, 2026
Aug 14, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 10, 2026
Aug 10, 2026
Aug 08, 2026
Aug 08, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026

Ähnlich wie PHIO